Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-23-023385
Filing Date
2023-08-11
Accepted
2023-08-11 20:16:16
Documents
2
Period of Report
2023-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1352
2 davidsonpoa.htm EX-24 7759
  Complete submission text file 0001437749-23-023385.txt   10799
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST MAIN STREET SUITE 101 CHARLOTTESVILLE VA 22902
Business Address
DAVIDSON JILL (Reporting) CIK: 0001989900 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 231165829